232 related articles for article (PubMed ID: 10985303)
1. Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy.
Tirelli U; Spina M; Gaidano G; Vaccher E; Franceschi S; Carbone A
AIDS; 2000 Aug; 14(12):1675-88. PubMed ID: 10985303
[No Abstract] [Full Text] [Related]
2. Prognostic impact of highly active antiretroviral therapy in HIV-related Hodgkin's disease.
Ribera JM; Navarro JT; Oriol A; López-Guillermo A; Sureda A; Abella E; Hernández-Rivas JA; Xicoy B; Grau J; Batlle M; Feliu E
AIDS; 2002 Sep; 16(14):1973-6. PubMed ID: 12351963
[No Abstract] [Full Text] [Related]
3. AIDS oncology.
O'Connor PG; Scadden DT
Infect Dis Clin North Am; 2000 Dec; 14(4):945-65, vii. PubMed ID: 11144646
[TBL] [Abstract][Full Text] [Related]
4. Reduced incidence of Kaposi's sarcoma and of systemic non-hodgkin's lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy.
Carrieri MP; Pradier C; Piselli P; Piche M; Rosenthal E; Heudier P; Durant J; Serraino D
Int J Cancer; 2003 Jan; 103(1):142-4. PubMed ID: 12455069
[No Abstract] [Full Text] [Related]
5. Management of AIDS-related non-Hodgkin's lymphomas.
Kersten MJ; Van Oers RH
Drugs; 2001; 61(9):1301-15. PubMed ID: 11511024
[TBL] [Abstract][Full Text] [Related]
6. The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era.
Vilchez RA; Finch CJ; Jorgensen JL; Butel JS
Medicine (Baltimore); 2003 Mar; 82(2):77-81. PubMed ID: 12640183
[TBL] [Abstract][Full Text] [Related]
7. Malignant lymphomas (ML) and HIV infection in Tanzania.
Mwakigonja AR; Kaaya EE; Mgaya EM
J Exp Clin Cancer Res; 2008 Jun; 27(1):9. PubMed ID: 18577266
[TBL] [Abstract][Full Text] [Related]
8. Raising awareness of non-Hodgkin lymphoma in HIV-infected adolescents: report of 2 cases in the HAART era.
Zangari P; Santilli V; Cotugno N; Manno E; Palumbo G; Lombardi A; De Vito R; Tchidjou H; Baldassari S; Ariganello P; Pontrelli G; De Florio F; Palma P; Bernardi S
J Pediatr Hematol Oncol; 2013 Apr; 35(3):e134-7. PubMed ID: 23426000
[TBL] [Abstract][Full Text] [Related]
9. HIV viremia and the development of AIDS-related lymphoma in patients treated with highly active antiretroviral therapy.
Sabin CA
J Infect Dis; 2009 Jul; 200(1):8-10. PubMed ID: 19476436
[No Abstract] [Full Text] [Related]
10. Human immunodeficiency virus-associated lung malignancies.
Lambert AA; Merlo CA; Kirk GD
Clin Chest Med; 2013 Jun; 34(2):255-72. PubMed ID: 23702175
[TBL] [Abstract][Full Text] [Related]
11. Epidemiologic trends in HIV-associated lymphomas.
Clarke CA; Glaser SL
Curr Opin Oncol; 2001 Sep; 13(5):354-9. PubMed ID: 11555712
[TBL] [Abstract][Full Text] [Related]
12. Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study.
; Bohlius J; Schmidlin K; Costagliola D; Fätkenheuer G; May M; Caro-Murillo AM; Mocroft A; Bonnet F; Clifford G; Karafoulidou A; Miro JM; Lundgren J; Chene G; Egger M
Antivir Ther; 2009; 14(8):1065-74. PubMed ID: 20032536
[TBL] [Abstract][Full Text] [Related]
13. HIV-Related Lymphoproliferative Diseases in the Era of Combination Antiretroviral Therapy.
Castelli R; Schiavon R; Preti C; Ferraris L
Cardiovasc Hematol Disord Drug Targets; 2020; 20(3):175-180. PubMed ID: 32294049
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus/acquired immunodeficiency syndrome and cancer: past, present, and future.
Engels EA; Goedert JJ
J Natl Cancer Inst; 2005 Mar; 97(6):407-9. PubMed ID: 15769998
[No Abstract] [Full Text] [Related]
15. AIDS-related lymphomas--potentially curable in the HAART era.
Valencia ME
AIDS Rev; 2006; 8(2):108-10. PubMed ID: 16848278
[No Abstract] [Full Text] [Related]
16. Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma.
Barta SK; Samuel MS; Xue X; Wang D; Lee JY; Mounier N; Ribera JM; Spina M; Tirelli U; Weiss R; Galicier L; Boue F; Little RF; Dunleavy K; Wilson WH; Wyen C; Remick SC; Kaplan LD; Ratner L; Noy A; Sparano JA
Ann Oncol; 2015 May; 26(5):958-966. PubMed ID: 25632071
[TBL] [Abstract][Full Text] [Related]
17. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
[TBL] [Abstract][Full Text] [Related]
18. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].
Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H
Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104
[TBL] [Abstract][Full Text] [Related]
19. Systemic chemotherapy for HIV-associated lymphoma in the era of highly active antiretroviral therapy.
Little RF; Yarchoan R; Wilson WH
Curr Opin Oncol; 2000 Sep; 12(5):438-44. PubMed ID: 10975551
[TBL] [Abstract][Full Text] [Related]
20. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy.
Molina A; Krishnan AY; Nademanee A; Zabner R; Sniecinski I; Zaia J; Forman SJ
Cancer; 2000 Aug; 89(3):680-9. PubMed ID: 10931469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
